Newsletter | January 14, 2025

01.14.25 -- 7 Focus Areas To Establish A Win-Win Relationship With Your CDMO

SPONSOR

Let Us Handle Your Buffer Preparation

Thermo Fisher Scientific is here to support you with the buffer preparation in your manufacturing workflow. Leaving the non-core activities to us enables you to focus on the patient therapy development. Our capabilities cover off-the-shelf products like WFI, NaOH, NaCl, or EtOH, a library of the most frequently used buffers that are made-to-order, as well as fully customized buffers.

FOCUS ON OUTSOURCING

7 Focus Areas To Establish A Win-Win Relationship With Your CDMO

Working with a CDMO doesn’t always go as planned. This article outlines the factors that will impact project success and set up a “win-win” relationship.

Exploring The Cost Considerations Of Immune Cell Therapies

Immune cell therapies have incredible potential for cancer treatment, and making them more cost effective is a critical consideration for improving patient access and outcomes.

The Potential Of Intensified Scalable Adherent Cell Culture — Part 2

Intensified adherent cell culture offers a promising solution to the limitations of traditional suspension culture, with the potential to improve efficiency, reduce costs, and accelerate development.

Tackling Cell & Gene Therapy Manufacturing Challenges

Allogeneic therapies are gaining popularity due to diversity, scalability, and affordability. A partner with innovative solutions can help streamline the path from discovery to commercialization.

Continuous Biomanufacturing: N-1 Tech For Higher Productivity, Quality

Among the numerous benefits of N-1 technology-backed CM are reduced bioreactor size, standardized sizes, a simplified process, and the potential to utilize single-use bioreactors (SUBs).

The 5 Key Risks Of Failing To Select The Right CDMO Partner

For complex projects involving oral solid dosage (OSD) and sterile drug products, selecting the ideal CDMO can play a pivotal role in determining the success of a drug candidate.

Simulated Control Strategy For Product Diversion Management

Learn about a manufacturing platform that integrates perfusion bioreactor technology; continuous product capture, low pH viral inactivation, and polishing steps; viral filtration, and formulation steps.

Supporting The Unique Needs Of Your Sterile Injectable

Leveraging the experience and specialized technology of a reliable CDMO partner is essential to ensure your sterile injectable therapeutic's safety and quality while delivering at speed.

Seasonal Vaccine Manufacturing

Explore how our contract manufacturing solutions can help you meet the growing demand for seasonal influenza vaccines efficiently and effectively.

Biopharma 4.0 – Digital Transformation In The Biopharma Industry

Biopharma 4.0 advances include the widespread automation of business processes within a company, comprehensive data integration, and interoperability between manufacturing and operations.

Leveraging The Immunological Diversity Of The Pentamice Platform

Consider this alternative immunization approach — a collection of five wildtype mouse strains bred for increased MHC class II diversity — and how we're leveraging it for COVID-19 antibody discovery.

OUTSOURCING SOLUTIONS

A Platform For Lentivirus-Based Cell And Gene Therapy Manufacturing - MilliporeSigma

Capacity Update October 2024 - AGC Biologics

Manufacturing Life-Saving Gene Therapies - Andelyn Biosciences

Technology Platforms - ElevateBio

Capacity Update October 2024: Large Molecule Drug Substance - Northway Biotech

Microbial Expertise - Boehringer Ingelheim Biopharmaceuticals GmbH

Connect With Bioprocess Online: